Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
Top Cited Papers
Open Access
- 17 October 2012
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 60 (19) , 1888-1898
- https://doi.org/10.1016/j.jacc.2012.08.986
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levelsProceedings of the National Academy of Sciences, 2009
- PCSK9: a convertase that coordinates LDL catabolismJournal of Lipid Research, 2009
- The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African populationAtherosclerosis, 2007
- Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosisJournal of Lipid Research, 2007
- Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases DegradationJournal of Biological Chemistry, 2007
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotypeProceedings of the National Academy of Sciences, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002